Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Age on Latanoprost Efficacy in Glaucoma
NCT00224289Phase 4Completed
- Sponsor
- Yale University
- Start
- Mar 2005
- Primary completion
- Apr 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of latanoprost in Glaucoma, ocular hypertension, sponsored by Yale University. Started Mar 2005; status: completed.
02
Drugs
latanoprost
03
Conditions
Glaucomaocular hypertension
Beyond the preview
Go deeper on NCT00224289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00224289.